Long COVID Fatigue Neurostimulation Study (LIFT)

A 20-week remote study of an at-home brain stimulation headband for fatigue in women with long COVID
See If You Qualify

Researchers are studying whether at-home brain stimulation can be delivered safely and practically over an extended course in women living with long COVID fatigue. LIFT is a 20-week remote study of the Lutea™ headband, an investigational device that delivers transcranial direct current stimulation (tDCS) in 20-minute sessions you complete yourself at home. Everything happens through the Alethios app, with no clinic visits and no exercise or exertion testing. Every participant receives the active device, and participants receive up to $250 paid as each phase of the study is completed.

About This Study

At-Home Remote Study
No clinic visits required. Screening, consent, all questionnaires, and every stimulation session are completed from home through the Alethios app.
Study Device Provided
The Lutea™ headband is shipped to you at no cost, along with video training and a how-to guide. You return it in prepaid packaging at the end of the study. Lutea™ is an investigational device and has not been cleared by the FDA for use in long COVID.
Milestone Compensation up to $250
Participants receive up to $250, paid as each phase is completed: $50 after the 4-week baseline period, $150 after the 12-week stimulation period, and $50 after the 4-week follow-up. Payment is based on completing each phase, not on how many stimulation sessions you complete.
No Placebo Group
This is a single-group exploratory study. Every participant receives the active device, and everyone knows they are receiving it. Because there is no comparison group, the study cannot show whether the device works, and no benefit is promised.

What's Involved

The study runs for 20 weeks and is fully remote. For the first four weeks you use no device at all and simply complete a daily fatigue rating plus a short medication and activity log, with a fatigue questionnaire every two weeks. For the next twelve weeks you complete five 20-minute stimulation sessions in each 7-day period, at whatever times work for you. The headband logs each session automatically, and you answer a brief tolerability check afterward. Once a month you complete a longer set of questionnaires covering sleep, mood, anxiety, quality of life, post-exertional malaise, and your overall sense of change. For the final four weeks you stop using the device and continue the questionnaires so the study can see whether any changes last.

Check Eligibility and Enroll

Complete a short screening questionnaire to see whether you qualify. If you are eligible, the study team reviews your answers, and you can read through the full consent form at your own pace and sign it electronically through the Alethios platform. You can ask the study team questions at any point before you sign.

Complete Onboarding and Your 4-Week Baseline Period

Your headband is shipped to you, along with instructional videos and a how-to guide. For the first four weeks you do not use the device at all. Instead you complete a daily fatigue rating and a short medication and activity log, plus a fatigue questionnaire every two weeks. This baseline period is how the study measures your usual pattern before stimulation starts. A $50 gift card is sent to adherent participants once this phase is complete.

Begin Your 12-Week At-Home Stimulation Course

You complete five 20-minute stimulation sessions in each 7-day period for twelve weeks, at times that suit you. The device logs every session automatically and syncs it to the study. After each session you answer a brief tolerability check, and you continue the daily and every-two-week questionnaires plus a monthly set covering sleep, mood, and quality of life. The study team monitors your data weekly and you can reach them at any time. $150 Amazon Gift Card is distributed to adherent participants once this phase is complete.

Complete Your 4-Week Follow-Up and Return the Device

For the final four weeks you stop using the device and continue the questionnaires so the study can see whether any changes last. You then return the headband in the prepaid packaging provided. A final $50 Amazon Gift Card is distributed once this phase is complete, bringing the total to $250 across the 20-week study.

What's Being Studied?

Fatigue is the most common and most disabling symptom of long COVID, and there is currently no approved treatment for it. Transcranial direct current stimulation (tDCS) delivers a weak, constant electrical current between two scalp electrodes to modulate activity in brain regions involved in fatigue, attention, and mood. The goal of this trial is to understand whether an extended at-home course is practical and well tolerated, how fatigue and related symptoms change over time, and what a future controlled trial would need to look like.

Am I eligible?

You may be eligible if you meet the following requirements

See If You Qualify
Adults aged 18 to 65
Sex assigned at birth female (the study device is developed for a female population)
Living in the United States
A long COVID or post-COVID condition diagnosis in your medical records, or COVID-related symptoms lasting more than about three months
Ongoing fatigue that significantly affects your daily life, confirmed by study questionnaires at screening and during the baseline period
You can take part whether or not you have an ME/CFS diagnosis or experience post-exertional malaise. No exercise or exertion testing is involved.
No epilepsy or seizure disorder, and no immediate family history of epilepsy
No metal or electronic implants in the head or neck, and no history of stroke, TIA, brain surgery, brain tumor, or other significant neurological condition
No active scalp conditions where the device sits, such as open wounds, infection, eczema, psoriasis, or significant scarring
No diagnosis of schizophrenia or bipolar disorder, and no history of suicidal behavior or significant self-injury
Not pregnant, breastfeeding, or planning a pregnancy during the study
No other known medical cause for your fatigue, such as untreated thyroid disease, sleep apnea, or significant anemia
Willing to keep your current medications and supplements stable throughout the study
A compatible smartphone (iOS 13.4 or later, or Android 12 or later) with a data plan, and fluent in English
Not enrolled in another long COVID clinical trial in the past three months